Ranitidine HCl 150 mg

Indication :
– Duodenal ulcer and benign gastric ulcer, including that associated with non-steroidal anti-inflammatory drug (including Acetosal) associated duodenal ulcers, especially in patients with a history of peptic ulcer disease.
– The treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome and systemic mastocytosis).
– Treatment of reflux oesophagitis.
– Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers.
– The treatment of chronic episodic dyspepsia, characterized by pain (epigastric or retrosternal) which is related to meals or disturbed sleep but not associated with the above conditions.
– Post-operative ulcers.
– Prophylaxis of stress ulceration in seriously ill.
– Prophylaxis of recurrent harmorrhage from peptic ulcer.
– Prophylaxis of Mendelson’s syndrome.

Composition : Each Ranitidine HCl Film coated tablet 150 mg contains Ranitidine HCl equivalent to Ranitidine 150 mg.
Contain of expicients: Microcrystalline cellulose PH 102, Pregelatinized Starch, Colloidal silicon dioxide, Mg stearate, Hypomellose 615, Ethylcellulose, Talcum, Titanium dioxide, Lake Green CJ04, Polysorbate 80, Isopropil alkohol, Methylen chloride

Presentation : Ranitidine HCl Film coated tablet 150 mg
Box, 10 strips @ 10 film coated tablets

On medical prescription only.
Store below 25⁰C and dry place, protect from light